Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 674

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Nickel carcinogenesis

Kasprzak, Kazimierz S, Sunderman, F.William, Salnikow, Konstantin·2003·Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
DOI 10.1016/j.mrfmmm.2003.08.021
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mrfmmm.2003.08.021

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 309

  1. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 49, Chromium, Nickel and Welding, IARC Scientific Publications, Lyon, 1990, pp. 257–445.
  2. F.W. Sunderman Jr., Nickel, in: M. Anke, M. Ihnat, M. Stoeppler (Eds.), Elements and their Compounds in the Environment, Wiley/VCH, Weinheim, in press.
  3. Barceloux, 1999, Nickel, Clin. Tox., 37, 239
  4. Coogan, 1989, Toxicity and carcinogenicity of nickel compounds, Crit. Rev. Toxicol., 19, 341, 10.3109/10408448909029327 · doi:10.3109/10408448909029327
  5. Denkhaus, 2002, Nickel essentiality, toxicity, and carcinogenicity, Crit. Rev. Oncol. Hematol., 42, 35, 10.1016/S1040-8428(01)00214-1 · DOI · Paper page
  6. R.P. Hausinger, Biochemistry of Nickel, Plenum Press, New York, 1993. · doi:10.1007/978-1-4757-9435-9
  7. E. Nieboer, J.O. Nriagu (Eds.), Nickel and Human Health, Wiley, New York, 1992.
  8. Ragsdale, 1998, Nickel biochemistry, Curr. Opin. Chem. Biol., 2, 208, 10.1016/S1367-5931(98)80062-8 · DOI
  9. Savolainen, 1996, Biochemical and clinical aspects of nickel toxicity, Rev. Environ. Health, 11, 167, 10.1515/REVEH.1996.11.4.167 · doi:10.1515/reveh.1996.11.4.167
  10. F.W. Sunderman Jr., Nickel, in: H.G. Seiler, H. Sigel, A. Sigel (Eds.), Handbook on Toxicity of Inorganic Compounds, Marcel Dekker, New York, 1988, pp. 453–468.
  11. F.W. Sunderman Jr., Nickel, in: J.B. Sullivan Jr., G.R. Krieger (Eds.), Clinical Environmental Health and Toxic Exposures, Williams and Wilkins, Baltimore, 2001, pp. 905–910.
  12. Sunderman, 1986, Biological monitoring of nickel, Toxicol. Ind. Health, 2, 17, 10.1177/074823378600200102 · doi:10.1177/074823378600200102
  13. Hopfer, 1985, Hypernickelemia in hemodialysis patients, Trace Elem. Med., 2, 68
  14. Fell, 1986, Trace metal contamination of albumin solutions used for plasma exchange, Lancet, 2, 467, 10.1016/S0140-6736(86)92181-1 · doi:10.1016/s0140-6736(86)92181-1
  15. Leach, 1985, Nickel contamination of human serum albumin solutions, N. Engl. J. Med., 313, 1232, 10.1056/NEJM198511073131921 · doi:10.1056/nejm198511073131921
  16. Leach, 1987, Hypernickelemia following coronary arteriography, caused by nickel in the radiographic contrast medium, Ann. Clin. Lab. Sci., 17, 137
  17. Gordon, 1994, Generalized sensitivity from an implanted orthopaedic antibiotic minichain containing nickel, Contact Dermat., 30, 181, 10.1111/j.1600-0536.1994.tb00709.x · doi:10.1111/j.1600-0536.1994.tb00709.x
  18. J.J. Hostynek, H.I. Maibach, Nickel and the Skin, CRC Press, Boca Raton, 2002, pp. 1–249. · doi:10.1201/b14242
  19. T. Norseth, M. Piscator, Nickel, in: L. Friberg, G.F. Nordberg, V.B. Vouk (Eds.), Handbook on the Toxicology of Metals, Elsevier/North-Holland Biomedical Press, Amsterdam, 1979, pp. 541–553.
  20. P. Grandjean, Human exposure to nickel, in: F.W. Sunderman Jr., (Ed.), Nickel in the Human Environment, vol. 53, IARC Scientific Publications, Lyon,1984, pp. 469–485.
  21. Baader, 1937, Berufkrebs, Neu. Ergeb. Geb. Krebskrankh, 1, 104
  22. National Academy of Sciences (NAS) Nickel, Medical and Biologic Effects of Environmental Pollutants, NAS Press, Washington, DC, 1975, pp. 1–277.
  23. Doll, 1990, Report of the International Committee on Nickel Carcinogenesis in Man, Scand. J. Work. Environ. Health, 16, 9
  24. Grimsrud, 2003, Lung cancer incidence among Norwegian nickel-refinery workers, 1953–2000, J. Environ. Monit., 5, 190, 10.1039/b211722n · doi:10.1039/b211722n
  25. K.S. Kasprzak, Animal studies, an overview, in: E. Nieboer, J.O. Nriagu (Eds.), Nickel and Human Health: Current Perspectives, Wiley, New York, 1992, pp. 387–420.
  26. Oller, 1997, Carcinogenicity assessment of selected nickel compounds, Toxicol. Appl. Pharmacol., 143, 152, 10.1006/taap.1996.8075 · DOI · Paper page
  27. Sunderman, 1973, The current status of nickel carcinogenesis, Ann. Clin. Lab. Sci., 3, 157
  28. F.W. Sunderman Jr., Carcinogenicity of nickel compounds in animals, in: F.W. Sunderman Jr., (Ed.), Nickel in the Human Environment, vol. 53, IARC Scientific Publications, Lyon, 1984, pp. 127–142.
  29. Sunderman, 1989, Histopathology of sinonasal and lung cancers in nickel refinery workers, Ann. Clin. Lab. Sci., 19, 44
  30. Hughes, 1995, Speciation and health risk assessment of metals: evaluation of effects associated with forms present in the environment, Regul. Toxicol. Pharmacol., 22, 213, 10.1006/rtph.1995.0003 · doi:10.1006/rtph.1995.0003
  31. Sunderman, 1989, Carcinogenicity of metal alloys in orthopedic prostheses: clinical and experimental studies, Fundam. Appl. Toxicol., 13, 205, 10.1016/0272-0590(89)90257-1 · DOI
  32. J.K. Avery, A. Goldberg, K.S. Kasprzak, L.C. Lucas, H.D. Millard, J.R. Natiella, R. Rhyne, N.W. Rupp, D.F. Williams, Local tissue reaction and carcinogenesis (Section Report), in: B.R. Lang, H.F. Morris, M.E. Razzoog, (Eds.), Biocompatibility, Toxicity, and Hypersensitivity to Alloy Systems Used in Dentistry, University of Michigan, Ann Arbor, 1986, pp. 262–270.
  33. McGregor, 2000, Evaluation of the carcinogenic risks to humans associated with surgical implants and other foreign bodies—a report of an IARC Monographs Programme Meeting, Eur. J. Cancer, 36, 307, 10.1016/S0959-8049(99)00312-3 · DOI · Paper page
  34. Campbell, 1943, Lung tumours in mice and man, Br. Med. J., 1, 179, 10.1136/bmj.1.4284.179 · doi:10.1136/bmj.1.4284.179
  35. Poirier, 1984, Inhibition by magnesium and calcium acetates of lead subacetate- and nickel acetate-induced lung tumors in strain A mice, Cancer Res., 44, 1520
  36. Kasprzak, 1990, Initiation by nickel acetate and promotion by sodium barbital of renal cortical epithelial tumors in male F344 rats, Carcinogenesis, 11, 647, 10.1093/carcin/11.4.647 · doi:10.1093/carcin/11.4.647
  37. F. Pott, M. Rippe, M. Roller, M. Csicsaky, M. Rosenbruch, Carcinogenicity of nickel compounds and nickel alloys in rats by intraperitoneal injection, in: E. Nieboer, J.O. Nriagu (Eds.), Nickel and Human Health: Current Perspectives, Wiley, New York, 1992, pp. 491–502.
  38. Diwan, 1992, Transplacental carcinogenic effects of nickel(II) acetate in the renal cortex, Carcinogenesis, 13, 1351, 10.1093/carcin/13.8.1351 · doi:10.1093/carcin/13.8.1351
  39. Gilman, 1962, Metal carcinogenesis. II. A study on the carcinogenic activity of cobalt, copper, iron, and nickel compounds, Cancer Res., 22, 158
  40. Hildebrand, 1979, Cylindrical laminated bodies in nickel-subsulphide-induced rhabdomyosarcoma in rabbits, Eur. J. Cell. Biol., 19, 276
  41. Sunderman, 1977, Carcinogenicity of nickel subsulfide in Fischer rats and Syrian hamsters after administration by various routes, Adv. Exp. Med. Biol., 91, 57, 10.1007/978-1-4684-0796-9_4 · doi:10.1007/978-1-4684-0796-9_4
  42. Yamashiro, 1980, Nickel sulphide-induced rhabdomyosarcomata in rats, Acta Pathol. Jpn., 30, 9
  43. Kasprzak, 1983, Carcinogenicity of nickel(II)hydroxides and nickel(II)sulfate in Wistar rats and its relation to the in vitro dissolution rates, Carcinogenesis, 4, 275, 10.1093/carcin/4.3.275 · DOI
  44. Shibata, 1989, Induction of soft tissue tumours in F344 rats by subcutaneous, intramuscular, intra-articular, and retroperitoneal injection of nickel sulphide (Ni3S2), J. Pathol., 157, 263, 10.1002/path.1711570314 · doi:10.1002/path.1711570314
  45. Onkelinx, 1973, Compartmental analysis of the metabolism of 63Ni(II) in rats and rabbits, Res. Commun. Chem. Pathol. Pharmacol., 6, 663
  46. Oskarsson, 1979, Fate of nickel subsulfide during carcinogenesis studied by autoradiography and X-ray powder diffraction, Cancer Res., 39, 4175
  47. Sano, 1988, Histopathological and immunohistochemical studies on nickel sulfide-induced tumors in F344 rats, Jpn. J. Cancer Res., 79, 212, 10.1111/j.1349-7006.1988.tb01579.x · doi:10.1111/j.1349-7006.1988.tb01579.x
  48. Stoner, 1976, Test for carcinogenicity of metallic compounds by the pulmonary tumor response in strain A mice, Cancer Res., 36, 1744
  49. Saknyn, 1978, Development of malignant tumors in rats under the influence of nickel-containing aerosols, Vopr. Onkol., 24, 44
  50. Parker, 1974, Distribution of 63Ni in rabbit tissues following intravenous injection of 63NiCl2, Res. Commun. Chem. Pathol. Pharmacol., 7, 755
  51. Jasmin, 1976, Renal carcinomas and erythrocytosis in rats following intrarenal injection of nickel subsulfide, Lab. Invest., 35, 71
  52. Jasmin, 1977, The topical effects of nickel subsulfide on renal parenchyma, Adv. Exp. Med. Biol., 91, 69, 10.1007/978-1-4684-0796-9_5 · doi:10.1007/978-1-4684-0796-9_5
  53. Sunderman, 1979, Induction of renal cancers in rats by intrarenal injection of nickel subsulfide, J. Environ. Pathol. Toxicol., 2, 1511
  54. Kasprzak, 1994, Iron accelerates while magnesium inhibits nickel-induced carcinogenesis in the rat kidney, Toxicology, 90, 129, 10.1016/0300-483X(94)90211-9 · doi:10.1016/0300-483x(94)90211-9
  55. Jasmin, 1975, Polycythemia induced in rats by intrarenal injection of nickel sulfide, Ni3S2, Proc. Soc. Expl. Biol. Med., 148, 774, 10.3181/00379727-148-38628 · doi:10.3181/00379727-148-38628
  56. Solymoss, 1978, Studies of the mechanism of polycythemia induced in ras by Ni3S2, Exp. Hematol., 6, 43
  57. Sunderman, 1984, Association between erythrocytosis and renal cancers in rats following intrarenal injection of nickel compounds, Carcinogenesis, 5, 1511, 10.1093/carcin/5.11.1511 · doi:10.1093/carcin/5.11.1511
  58. Damjanov, 1978, Induction of testicular sarcoma in Fischer rats by intratesticular injection of nickel subsulfide, Cancer Res., 38, 268
  59. Albert, 1982, Induction of ocular neoplasms in Fischer rats by intraocular injection of nickel subsulfide, Invest. Ophthalmol. Vis. Sci., 22, 768
  60. Okamoto, 1987, Induction of ocular tumor by nickel subsulfide in the Japanese common newt, Cynops pyrrhogaster, Cancer Res., 47, 5213
  61. Sunderman, 1959, Nickel poisoning. IX. Carcinogenesis in rats exposed to nickel carbonyl, Arch. Ind. Health, 20, 36
  62. Ottolenghi, 1975, Inhalation studies of nickel sulfide in pulmonary carcinogenesis of rats, J. Natl. Cancer Inst., 54, 1165, 10.1093/jnci/54.5.1165 · doi:10.1093/jnci/54.5.1165
  63. Yarita, 1978, Carcinogenicity of nickel subsulfide for respiratory tract mucosa, Cancer Res., 38, 3140
  64. Dunnick, 1955, Comparative carcinogenic effects of nickel subsulfide, nickel oxide, or nickel sulfate hexahydrate chronic exposures in the lung, Cancer Res., 55, 5251
  65. Maenza, 1971, Rapid induction of sarcomas in rats by combination of nickel sulfide and 3,4-benzpyrene, Cancer Res., 31, 2067
  66. Kasprzak, 1973, Pathological reactions in rat lungs following intratracheal injection of nickel subsulfide and 3,4-benzpyrene, Res. Commun. Chem. Pathol. Pharmacol., 6, 237
  67. Sunderman, 1976, Effect of manganese on carcinogenicity and metabolism of nickel subsulfide, Cancer Res., 36, 1790
  68. Sunderman, 1983, Effects of manganese compounds on carcinogenicity of nickel subsulfide in rats, Carcinogenesis, 4, 461, 10.1093/carcin/4.4.461 · doi:10.1093/carcin/4.4.461
  69. Kasprzak, 1985, Effects of calcium and magnesium salts on nickel subsulfide carcinogenicity in Fischer rats, Carcinogenesis, 6, 1161, 10.1093/carcin/6.8.1161 · doi:10.1093/carcin/6.8.1161
  70. Kasprzak, 1987, Nickel–magnesium interactions in carcinogenesis: dose–effects and involvement of natural killer cells, Carcinogenesis, 8, 1005, 10.1093/carcin/8.7.1005 · DOI
  71. Kasprzak, 1988, Inhibitory effect of zinc on nickel subsulfide carcinogenesis in Fischer rats, Toxicology, 52, 253, 10.1016/0300-483X(88)90130-8 · DOI
  72. Kasprzak, 1994, Iron accelerates while magnesium inhibits nickel-induced carcinogenesis in the rat kidney, Toxicology, 90, 129, 10.1016/0300-483X(94)90211-9 · doi:10.1016/0300-483x(94)90211-9
  73. K.S. Kasprzak, R.E. Rodriguez, Inhibitory effects of zinc, magnesium, and iron on nickel subsulfide carcinogenesis in rat skeletal muscle, in: E. Nieboer, J.O. Nriagu (Eds.), Nickel in Human Health: Current Perspectives, Wiley, New York, 1992, pp. 545–559.
  74. Sunderman, 1983, Organ and species specificity in nickel subsulfide carcinogenesis, Basic Life Sci., 24, 107
  75. Rodriguez, 1996, Relative susceptibilities of C57BL/6, (C57BL/6×C3H/He)F1, and C3H/He mice to acute toxicity and carcinogenicity of nickel subsulfide, Toxicology, 107, 131, 10.1016/0300-483X(95)03251-A · doi:10.1016/0300-483x(95)03251-a
  76. Daniel, 1966, Strain differences in the response of rats to the injection of nickel sulphide, Br. J. Cancer, 20, 886, 10.1038/bjc.1966.102 · doi:10.1038/bjc.1966.102
  77. Rodriguez, 1991, Nickel-induced lipid peroxidation in the liver of different strains of mice and its relation to nickel effects on antioxidant systems, Toxicol. Lett., 57, 269, 10.1016/0378-4274(91)90201-G · doi:10.1016/0378-4274(91)90201-g
  78. Fisher, 1986, Lifetime effects of intratracheally instilled nickel subsulfide on B6C3F1 mice, Environ. Res., 40, 313, 10.1016/S0013-9351(86)80106-2 · doi:10.1016/s0013-9351(86)80106-2
  79. Sunderman, 1981, Recent research on nickel carcinogenesis, Environ. Health Perspect., 40, 131, 10.1289/ehp.8140131 · doi:10.1289/ehp.8140131
  80. Eitinger, 2000, Nickel transport systems in microorganisms, Arch. Microbiol., 173, 1, 10.1007/s002030050001 · DOI · Paper page
  81. Pikalek, 1983, The mutagenic activity of nickel in Corynebacterium sp., Folia Microbiol. (Praha), 28, 17, 10.1007/BF02877379 · doi:10.1007/bf02877379
  82. DiPaolo, 1979, Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts, Cancer Res., 39, 1008
  83. Biedermann, 1987, Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts, Cancer Res., 47, 3815
  84. Patierno, 1993, Transformation of rat tracheal epithelial cells to immortal growth variants by particulate and soluble nickel compounds, Mutat. Res., 300, 179, 10.1016/0165-1218(93)90049-J · DOI
  85. M. Costa, Mechanisms of nickel genotoxicity and carcinogenicity, in: L.W. Chang (Ed.), Toxicology of Metals, CRC Press, Boca Raton, 1996, pp. 245–251. · doi:10.1201/9781003418917-23
  86. Kerckaert, 1996, Use of the Syrian hamster embryo cell transformation assay for determining the carcinogenic potential of heavy metal compounds, Fundam. Appl. Toxicol., 34, 67, 10.1006/faat.1996.0176 · DOI
  87. Costa, 1979, Induction of sarcomas in nude mice by implantation of Syrian hamster fetal cells exposed in vitro to nickel subsulfide, Cancer Res., 39, 3591
  88. Trott, 1995, Mechanisms involved in the immortalization of mammalian cells by ionizing radiation and chemical carcinogens, Carcinogenesis, 16, 193, 10.1093/carcin/16.2.193 · DOI
  89. Hansen, 1983, In vitro toxicity and transformation potency of nickel compounds, Environ. Health Perspect., 51, 223, 10.1289/ehp.8351223 · doi:10.1289/ehp.8351223
  90. Saxholm, 1981, Oncogenic transformation and cell lysis in C3H/10T 1/2 cells and increased sister chromatid exchange in human lymphocytes by nickel subsulfide, Cancer Res., 41, 4136
  91. Tveito, 1989, Immortalization of normal human kidney epithelial cells by nickel(II), Cancer Res., 49, 1829
  92. Haugen, 1989, Transformation of human kidney epithelial cells to tumorigenicity by nickel(II) and v-Ha-ras oncogene, Biol. Trace Element Res., 21, 451, 10.1007/BF02917288 · doi:10.1007/bf02917288
  93. Rivedal, 1981, Metal salts as promoters of in vitro morphological transformation of hamster embryo cells initiated by benzo[a]pyrene, Cancer Res., 41, 2950
  94. Miki, 1987, Inhibition of intercellular communication by nickel(II): antagonistic effect of magnesium, Carcinogenesis, 8, 1757, 10.1093/carcin/8.11.1757 · doi:10.1093/carcin/8.11.1757
  95. Foulkes, 1986, On the mechanism of nickel absorption in the rat jejunum, Toxicology, 38, 35, 10.1016/0300-483X(86)90170-8 · DOI
  96. Refvik, 1995, Surface binding and uptake of nickel(II) in human epithelial kidney cells: modulation by ionomycin, Carcinogenesis, 16, 1107, 10.1093/carcin/16.5.1107 · doi:10.1093/carcin/16.5.1107
  97. Zaroogian, 1993, Effect of selected inhibitors on cadmium, nickel, and benzo[a]pyrene uptake into brown cells of Mercenaria mercenaria, Marine Environ. Res., 35, 41, 10.1016/0141-1136(93)90011-N · doi:10.1016/0141-1136(93)90011-n
  98. Azula, 1993, Ni2+ impairs thrombin-induced signal transduction by acting on the agonist and/or receptor in human platelets, Am. J. Physiol., 265, C1681, 10.1152/ajpcell.1993.265.6.C1681 · doi:10.1152/ajpcell.1993.265.6.c1681
  99. Tallkvist, 1994, Enhanced intestinal nickel absorption in iron-deficient rats, Pharmacol. Toxicol., 75, 244, 10.1111/j.1600-0773.1994.tb00355.x · doi:10.1111/j.1600-0773.1994.tb00355.x
  100. Schafer, 1983, The influence of tin, nickel, and cadmium on the intestinal absorption of iron, Ecotoxicol. Environ. Safety, 7, 87, 10.1016/0147-6513(83)90052-0 · doi:10.1016/0147-6513(83)90052-0
  101. Muller-Fassbender, 2003, Different behaviour of 63Ni and 59Fe during absorption in iron-deficient and iron-adequate jejunal rat segments ex vivo, Toxicology, 185, 141, 10.1016/S0300-483X(02)00600-5 · DOI
  102. Tallkvist, 1998, Transport of nickel across monolayers of human intestinal Caco-2 cells, Toxicol. Appl. Pharmacol., 151, 117, 10.1006/taap.1998.8453 · doi:10.1006/taap.1998.8453
  103. Knopfel, 2000, Characterization of an integral protein of the brush border membrane mediating the transport of divalent metal ions, Biophys. J., 79, 874, 10.1016/S0006-3495(00)76343-0 · DOI
  104. Ghio, 1998, Metal storage and transport proteins increase after exposure of the rat lung to an air pollution particles, Toxicol. Pathol., 26, 388, 10.1177/019262339802600313 · DOI
  105. Costa, 1981, Phagocytosis, cellular distribution, and carcinogenic activity of particulate nickel compounds in tissue culture, Cancer Res., 41, 2868
  106. Heck, 1982, Surface reduction of amorphous NiS particles potentiates their phagocytosis and subsequent induction of morphological transformation in Syrian hamster embryo cells, Cancer Lett., 15, 19, 10.1016/0304-3835(82)90071-4 · doi:10.1016/0304-3835(82)90071-4
  107. Kuehn, 1982, Phagocytosis of particulate nickel compounds by rat peritoneal macrophages in vitro, Carcinogenesis, 3, 321, 10.1093/carcin/3.3.321 · doi:10.1093/carcin/3.3.321
  108. Costa, 1981, Factors influencing the phagocytosis, neoplastic transformation, and cytotoxicity of particulate nickel compounds in tissue culture systems, Toxicol. Appl. Pharmacol., 60, 313, 10.1016/0041-008X(91)90234-6 · DOI
  109. Costa, 1980, Carcinogenic activity of particulate nickel compounds is proportional to their cellular uptake, Science, 209, 515, 10.1126/science.7394519 · DOI
  110. Evans, 1982, Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian cells, Cancer Res., 42, 2729
  111. Fletcher, 1994, Toxicity, uptake, and mutagenicity of particulate and soluble nickel compounds, Environ. Health Perspect., 102, 69
  112. Kasprzak, 1977, Mechanisms of dissolution of nickel subsulfide in rats serum, Res. Commun. Chem. Pathol. Pharmacol., 16, 95
  113. Kuehn, 1982, Dissolution half-times of nickel compounds in water, rat serum, and renal cytosol, J. Inorg. Biochem., 17, 29, 10.1016/S0162-0134(00)80227-5 · doi:10.1016/s0162-0134(00)80227-5
  114. A. Longstaff, A.I.T. Walker, R. Jackh, Nickel oxide, potential carcinogenicity—a review and further evidence, in: F.W. Sunderman (Ed.), Nickel in the Human Environment, vol. 53, IARC Scientific Publications, Lyon, 1984, pp. 235–244.
  115. Sen, 1987, Comparison of the localization of chromosome damage induced by calcium chromate and nickel compounds, Cancer Res., 47, 2142
  116. Conway, 1989, Nonrandom chromosomal alterations in nickel-transformed Chinese hamster embryo cells, Cancer Res., 49, 6032
  117. Sen, 1985, Incidence and localization of sister chromatid exchanges induced by nickel and chromium compounds, Cancer Res., 7, 1527
  118. Sahu, 1989, Effects of nickel sulfate, lead sulfate, and sodium arsenite alone and with UV light on sister chromatid exchanges in cultured human lymphocytes, J. Mol. Toxicol., 2, 129
  119. Arrouijal, 1990, Genotoxic activity of nickel subsulphide alpha-Ni3S2, Mutagenesis, 5, 583, 10.1093/mutage/5.6.583 · doi:10.1093/mutage/5.6.583
  120. Patierno, 1985, Preferential DNA–protein crosslinking by NiCl2 in magnesium-insoluble regions of fractionated Chinese hamster ovary cell chromatin, Cancer Res., 45, 5787
  121. Kasprzak, 1991, The role of oxidative damage in metal carcinogenicity, Chem. Res. Toxicol., 4, 604, 10.1021/tx00024a002 · DOI · Paper page
  122. S. Zienolddiny, D. Ryberg, A. Haugen, Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines, Carcinogenesis (2000) 1521–1526. · DOI
  123. Chiocca, 1991, Nickel mutagenesis: alteration of the MuSVts110 thermosensitive splicing phenotype by a nickel-induced duplication of the 3′ splice site, Mol. Carcinog., 4, 61, 10.1002/mc.2940040110 · DOI
  124. Rosetto, 1994, Characterization of nickel-induced mutations, Sci. Total Environ., 148, 201, 10.1016/0048-9697(94)90397-2 · doi:10.1016/0048-9697(94)90397-2
  125. Higinbotham, 1992, GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA, Cancer Res., 52, 4747
  126. Harty, 1996, p53 mutations and occupational exposures in a surgical series of lung cancers, Cancer Epidemiol. Biomark. Prev., 5, 997
  127. Biggart, 1986, Assessment of the uptake and mutagenicity of nickel chloride in Salmonella tester strains, Mutat. Res., 175, 209, 10.1016/0165-7992(86)90056-4 · DOI
  128. Kargacin, 1993, Mutagenic responses of nickel oxides and nickel sulfides in Chinese hamster V79 cell lines as the xanthine-guanine phosphoribosyl transferase locus, Mutat. Res., 300, 63, 10.1016/0165-1218(93)90141-Y · doi:10.1016/0165-1218(93)90141-y
  129. Lee, 1995, Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens, Mol. Cell. Biol., 15, 2547, 10.1128/MCB.15.5.2547 · DOI · Paper page
  130. Rodriguez-Arnaiz, 1986, Mutagenicity of nickel sulpate in Drosophila melanogaster, Mutat. Res., 170, 115, 10.1016/0165-1218(86)90023-6 · doi:10.1016/0165-1218(86)90023-6
  131. Dubins, 1986, Nickel(II) genotoxicity: potentiation of mutagenesis of simple alkylating agents, Mutat. Res., 162, 187, 10.1016/0027-5107(86)90085-0 · doi:10.1016/0027-5107(86)90085-0
  132. Mayer, 1998, Nickel subsulfide is genotoxic in vitro but shows no mutagenic potential in respiratory tract tissues of Big Blue rats and Muta Mouse mice in vivo after inhalation, Mutat Res., 420, 85, 10.1016/S1383-5718(98)00140-5 · DOI
  133. N.T. Christie, D.M. Tummolo, C.B. Klein, T.G. Rossman, Role of Ni(II) in mutation, in: E. Nieboer, J.O. Nriagu (Eds.), Nickel and Human Health: Current Perspectives, Wiley, New York, 1992, pp. 305–317.
  134. Biggart, 1987, Nickel-induced heritable alterations in retroviral transforming gene expression, J. Virol., 61, 2378, 10.1128/jvi.61.8.2378-2388.1987 · doi:10.1128/jvi.61.8.2378-2388.1987
  135. Broday, 2000, Nickel compounds are novel inhibitors of histone H4 acetylation, Cancer Res., 60, 238
  136. Sunderman, 1982, Erythropoietin-mediated erythrocytosis in rodents after intrarenal injection of nickel subsulfide, Yale J. Biol. Med., 55, 123
  137. Sunderman, 1984, Association between erythrocytosis and renal cancers in rats following intrarenal injection of nickel compounds, Carcinogenesis, 5, 1511, 10.1093/carcin/5.11.1511 · doi:10.1093/carcin/5.11.1511
  138. Semenza, 1992, A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation, Mol. Cell. Biol., 12, 5447
  139. Graven, 1998, Hypoxia regulation of endothelial glyceraldehyde-3-phosphate dehydrogenase, Am. J. Physiol., 43, 347, 10.1152/ajpcell.1998.274.2.C347 · DOI
  140. Salnikow, 2000, Carcinogenic nickel induces genes involved in hypoxic stress, Cancer Res., 60, 38
  141. Namiki, 1995, Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells, J. Biol. Chem., 270, 31189, 10.1074/jbc.270.52.31189 · DOI · Paper page
  142. Zhou, 1998, Cap43, a novel gene specifically induced by Ni2+ compounds, Cancer Res., 58, 2182
  143. Salnikow, 1999, Nickel-induced transformation shifts the balance between HIF-1α and p53 transcription factors, Carcinogenesis, 20, 1819, 10.1093/carcin/20.9.1819 · DOI
  144. Semenza, 2000, Expression of hypoxia-inducible factor 1: mechanisms and consequences, Biochem. Pharmacol., 59, 47, 10.1016/S0006-2952(99)00292-0 · DOI · Paper page
  145. Semenza, 2001, HIF-1, O2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus, Cell, 107, 1, 10.1016/S0092-8674(01)00518-9 · DOI · Paper page
  146. Carmeliet, 1998, Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis, Nature, 394, 485, 10.1038/28867 · DOI · Paper page
  147. Folkman, 1971, Tumor angiogenesis: therapeutic implications, N. Engl. J. Med., 285, 1182, 10.1056/NEJM197111182852108 · DOI · Paper page
  148. Semenza, 1994, Transcriptional regulation of genes encoding glycolitic enzymes by hypoxia-inducible factor 1, J. Biol. Chem., 269, 23757, 10.1016/S0021-9258(17)31580-6 · DOI · Paper page
  149. Melillo, 1995, A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter, J. Exp. Med., 182, 1683, 10.1084/jem.182.6.1683 · DOI · Paper page
  150. Garayoa, 2000, Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis, Mol. Endocrinol., 14, 848, 10.1210/mend.14.6.0473 · doi:10.1210/mend.14.6.0473 · Paper page
  151. Salnikow, 2002, The role of hypoxia-inducible signaling pathway in nickel carcinogenesis, Environ. Health Perspect., 110, 831, 10.1289/ehp.02110s5831 · DOI
  152. Salnikow, 2003, GeneChip analysis of signaling pathways effected by nickel, J. Environ. Monitor., 5, 1, 10.1039/b210262p · DOI
  153. Salnikow, 2003, The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis, Cancer Res., 63, 3524
  154. Salnikow, 2000, Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism, Cancer Res., 60, 3375
  155. Sutter, 2000, Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiqitination that is disrupted by deletions and missense mutations, Proc. Natl. Acad. Sci. U.S.A., 97, 4748, 10.1073/pnas.080072497 · DOI · Paper page
  156. Jewell, 2001, Induction of HIF-1alpha in response to hypoxia is instantaneous, FASEB J., 15, 1312, 10.1096/fj.00-0732fje · DOI · Paper page
  157. Jaakkola, 2001, Targeting of HIF-alpha to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation, Science, 292, 468, 10.1126/science.1059796 · DOI · Paper page
  158. Ohh, 2000, Ubiquination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel–Lindau protein, Nat. Cell Biol., 2, 423, 10.1038/35017054 · DOI · Paper page
  159. McNeill, 2002, Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803, Biochem J., 367, 571, 10.1042/bj20021162 · DOI · Paper page
  160. Salnikow, 1994, Loss of thrombospondin transcriptional activity in nickel-transformed cells, Mol. Cell. Biol., 14, 851
  161. Salnikow, 1997, Induction of activating transcription factor I by nickel and its role as a negative regulator of thrombospondin I gene expression, Cancer Res., 57, 5060
  162. Shaywitz, 1999, CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals, Annu. Rev. Biochem., 68, 821, 10.1146/annurev.biochem.68.1.821 · DOI · Paper page
  163. Goebeler, 1993, J. Invest. Dermatol., 100, 759, 10.1111/1523-1747.ep12476328 · DOI
  164. Goebeler, 1995, Activation of nuclear factor-kappa B and gene expression in human endothelial cells by the common haptens nickel and cobalt, J. Immunol., 155, 2459, 10.4049/jimmunol.155.5.2459 · DOI
  165. Hernandez-Boussard, 1999, IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines, Hum. Mutat., 14, 1, 10.1002/(SICI)1098-1004(1999)14:1<1::AID-HUMU1>3.0.CO;2-H · doi:10.1002/(sici)1098-1004(1999)14:1<1::aid-humu1>3.0.co;2-h
  166. Maehle, 1992, Altered p53 gene structure and expression in human epithelial cells after exposure to nickel, Cancer Res., 52, 218
  167. Weghorst, 1994, Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors, Cancer Res., 154, 215
  168. Shiao, 1998, Cell cycle arrest, apoptosis and p53 expression in nickel (II) acetate-treated Chinese hamster ovary cells, Carcinogenesis, 19, 1203, 10.1093/carcin/19.7.1203 · DOI
  169. An, 1998, Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha, Nature, 392, 405, 10.1038/32925 · DOI · Paper page
  170. Lee, 1988, Studies on the human retinoblastoma susceptibility gene, J. Cell. Biochem., 38, 213, 10.1002/jcb.240380309 · DOI
  171. Kouzarides, 1995, Transcriptional control by the retinoblastoma protein, Semin. Cancer Biol., 6, 91, 10.1006/scbi.1995.0012 · DOI
  172. Lin, 1994, Nickel-induced transformation of human cells causes loss of the phosphorylation of the retinoblastoma protein, Cancer Res., 54, 2751
  173. Rani, 1993, Transformation of immortal, non-tumorigenic osteoblast-like human osteosarcoma cells to the tumorigenic phenotype by nickel sulfate, Carcinogenesis, 14, 947, 10.1093/carcin/14.5.947 · doi:10.1093/carcin/14.5.947
  174. Lin, 1994, Transformation of human osteoblasts to anchorage-independent growth by insoluble nickel particles, Environ. Health Perspect., 102, 289
  175. Miller, 1998, Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride, Environ. Health Perspect., 106, 465, 10.1289/ehp.98106465 · doi:10.1289/ehp.98106465
  176. Trapasso, 2003, Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding, Proc. Natl. Acad. Sci. U.S.A., 100, 1592, 10.1073/pnas.0437915100 · DOI
  177. Kowara, 2002, In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals, Chem. Res. Toxicol., 15, 319, 10.1021/tx010112j · doi:10.1021/tx010112j
  178. R. Kowara, K. Salnikow, B.A. Diwan, R.M. Bare, M.P. Waalkes, K.S. Kasprzak, Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas, Mol. Cell. Biochem., in press.
  179. Lee, 1999, Nickel(II) acetate-treated Chinese hamster ovary cells differentially express vimentin, hSNF2H homologue, and H ferritin, Biochem. Biophys. Res. Commun., 258, 592, 10.1006/bbrc.1999.0692 · doi:10.1006/bbrc.1999.0692
  180. Lumb, 1988, The mechanism of malignant tumor induction by nickel subsulfide, Ann. Clin. Lab. Sci., 18, 353
  181. Burns, 1997, Protein complexes for remodeling chromatin, Biochem. Biophys. Acta, 1350, 159
  182. Cheng, 2003, Gene expression dose–response changes in microarrays after exposure of human peripheral lung epithelial cells to nickel(II), Toxicol. Appl. Pharmacol., 191, 22, 10.1016/S0041-008X(03)00228-X · DOI
  183. McDowell, 2000, Differential gene expression in the initiation and progression of nickel-induced acute lung injury, Am. J. Respir. Cell Mol. Biol., 23, 466, 10.1165/ajrcmb.23.4.4087 · DOI
  184. Sirover, 1976, Infidelity of DNA synthesis in vitro: screening for potential metal mutagens and carcinogens, Science, 194, 1434, 10.1126/science.1006310 · DOI · Paper page
  185. Hartwig, 1994, Nickel(II) interferes with the incision step in nucleotide excision repair in mammalian cells, Cancer, 54, 4045
  186. Hartwig, 1998, Carcinogenicity of metal compounds: possible role of DNA repair inhibition, Toxicol. Lett., 28, 102
  187. Iwitzki, 1998, Nickel(II) inhibits the repair of O6-methylguanine in mammalian cells, Arch. Toxicol., 72, 681, 10.1007/s002040050561 · DOI
  188. Schwerdtle, 2002, Effect of soluble and particulate nickel compounds on the formation and repair of stable benzo[a]pyrene DNA adducts in human lung cells, Carcinogenesis, 23, 47, 10.1093/carcin/23.1.47 · DOI
  189. Hartwig, 2002, Interference by toxic metal ions with zinc-dependent proteins involved in maintaining genomic sttability, Food Chem. Toxicol., 40, 1179, 10.1016/S0278-6915(02)00043-1 · DOI
  190. Bal, 2003, Mechanism of nickel assault on the zinc finger of DNA repair protein XPA, Chem. Res. Toxicol., 16, 242, 10.1021/tx025639q · DOI
  191. Hartwig, 2002, Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms, Environ. Health Perspect., 110, 797, 10.1289/ehp.02110s5797 · DOI · Paper page
  192. Kasprzak, 2000, Inhibition of antimutagenic enzymes, 8-oxo-dGTPases, J. Inorg. Biochem., 79, 231, 10.1016/S0162-0134(99)00240-8 · DOI
  193. Pozzan, 1994, Molecular and cellular physiology of intracellular calcium stores, Physiol. Rev., 74, 595, 10.1152/physrev.1994.74.3.595 · DOI · Paper page
  194. Rosen, 1995, Calcium regulation of gene expression, Adv. Second Messenger Phosphoprotein Res., 30, 225, 10.1016/S1040-7952(05)80009-6 · DOI
  195. Nicotera, 1988, The role of calcium in apoptosis, Cell Calcium, 23, 173, 10.1016/S0143-4160(98)90116-6 · DOI · Paper page
  196. K.S. Kasprzak, M.P. Waalkes, The role of calcium, magnesium, and zinc in carcinogenesis, in: L.A. Poirier, P.M. Newberne, M.W. Pariza, (Eds.), Essential Nutrients in Carcinogenesis, Plenum Press, New York, 1986, pp. 497–515. · DOI
  197. Swierenga, 1976, Alteration by malignant transformation of the calcium requirements for cell proliferation in vitro, J. Natl. Cancer Inst., 57, 125, 10.1093/jnci/57.1.125 · doi:10.1093/jnci/57.1.125
  198. Swierenga, 1978, Age-related and carcinogen-induced alterations of the extracellular growth factor requirements for cell proliferation in vitro, J. Cell. Physiol., 94, 171, 10.1002/jcp.1040940206 · doi:10.1002/jcp.1040940206
  199. Salnikow, 1999, Role of Ca2+ in the regulation of nickel-inducible Cap43 gene expression, Toxicol. Appl. Pharmacol., 160, 127, 10.1006/taap.1999.8759 · DOI
  200. Funakoshi, 1997, The mechanism of nickel uptake by rat primary hepatocyte cultures: role of calcium channels, Toxicology, 124, 21, 10.1016/S0300-483X(97)00131-5 · doi:10.1016/s0300-483x(97)00131-5

200 of 309 shown

Cited by

See all 674

Metadata

Authors
Kasprzak, K. S., Sunderman, F. W., & Salnikow, K.
Venue
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Publisher
Elsevier BV
Published
2003-12
Volume
533
Issue
1-2
Pages
67-97
ISSN
  • 0027-5107 (ISSN-L)
  • 1386-1964
DOI
10.1016/j.mrfmmm.2003.08.021
OpenAlex
W3205358246
Cited by
674
References
7
FWCI
14.69
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nickel carcinogenesis. https://app.cochat.ai/papers/10.1016/j.mrfmmm.2003.08.021
The paper
Kasprzak, K. S., Sunderman, F. W., & Salnikow, K. (2003). Nickel carcinogenesis. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. https://doi.org/10.1016/j.mrfmmm.2003.08.021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.